Callio Therapeutics

Callio Therapeutics is a biotechnology company focused on enabling multi-payload antibody-drug conjugates (ADCs) to improve cancer treatment. The company is committed to developing ADCs with differentiated payloads and linker technologies, allowing for the targeted delivery of drug combinations to tumor cells, empowering healthcare professionals to treat cancer.